These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22311930)

  • 41. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
    Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vogt-Koyanagi-Harada syndrome].
    Babushkin AE; Siuniaeva SI; Fattakhov BT; Vavilova OV
    Vestn Oftalmol; 2003; 119(2):43-5. PubMed ID: 13678012
    [No Abstract]   [Full Text] [Related]  

  • 43. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. VOGT-KOYANAGI DISEASE.
    Bennett FM
    Br J Ophthalmol; 1962 Sep; 46(9):563-7. PubMed ID: 18170815
    [No Abstract]   [Full Text] [Related]  

  • 45. [Rare form of uveitis with neurological symptoms: the Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
    Kätterer C; Kaeser HE; Steiger U
    Schweiz Med Wochenschr; 1992 Feb; 122(8):269-74. PubMed ID: 1542780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vogt-Koyanagi-Harada syndrome: review of clinical features.
    Pan D; Hirose T
    Semin Ophthalmol; 2011; 26(4-5):312-5. PubMed ID: 21958180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vogt-Koyanagi-Harada syndrome: apropos of 2 cases].
    Gabsi S; Hassoumi MH; Doss N; Mejri A; Othmani S; Bahri M
    Tunis Med; 1989 Dec; 67(12):817-20. PubMed ID: 2623779
    [No Abstract]   [Full Text] [Related]  

  • 48. Case of probable Vogt-Koyanagi-Harada syndrome: A rare presentation.
    Mehta KN; Daigavane S
    Indian J Ophthalmol; 2022 Jul; 70(7):2684-2686. PubMed ID: 35791205
    [No Abstract]   [Full Text] [Related]  

  • 49. Spectral domain optical coherence tomography and autofluorescence in a case of acute posterior multifocal placoid pigment epitheliopathy mimicking Vogt-Koyanagi-Harada disease: case report and review of literature.
    Lee GE; Lee BW; Rao NA; Fawzi AA
    Ocul Immunol Inflamm; 2011 Feb; 19(1):42-7. PubMed ID: 21034311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Topical Corticosteroid Monotherapy of a Patient with Vogt-Koyanagi-Harada Syndrome (VKH)].
    Skalicky N; Jesse M; Hatz-Wurziger K; Katamay R
    Klin Monbl Augenheilkd; 2022 Apr; 239(4):545-547. PubMed ID: 35472802
    [No Abstract]   [Full Text] [Related]  

  • 51. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease.
    Cuchacovich M; Solanes F; Díaz G; Cermenati T; Avila S; Verdaguer J; Verdaguer JI; Carpentier C; Stopel J; Rojas B; Traipe L; Gallardo P; Sabugo F; Zanoli M; Merino G; Villarroel F
    Ocul Immunol Inflamm; 2010 Jun; 18(3):200-7. PubMed ID: 20482399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vogt Koyanagi Harada syndrome in children: diagnosis and management].
    Benfdil N; Baha Ali T; Jellab B; Moutaouakil A
    Bull Soc Belge Ophtalmol; 2010; (314):15-8. PubMed ID: 20480746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The Vogt-Koyanagi-Harada uveomeningoencephalitic syndrome].
    Menger H; Neukäter W; Kroll S; Jörg J
    Nervenarzt; 1994 Aug; 65(8):553-6. PubMed ID: 7969653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vogt-Koyanagi-Harada syndrome: what neurologists need to know.
    Lueck CJ
    Pract Neurol; 2019 Aug; 19(4):278-281. PubMed ID: 30890585
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Read RW; Yu F; Accorinti M; Bodaghi B; Chee SP; Fardeau C; Goto H; Holland GN; Kawashima H; Kojima E; Lehoang P; Lemaitre C; Okada AA; Pivetti-Pezzi P; Secchi A; See RF; Tabbara KF; Usui M; Rao NA
    Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vogt-Koyanagi-Harada syndrome: a serious and rare emergency in children].
    Venaille A; Palombi K; Templier I; Bouillet L; Pagnier A; Debillon T; Bourdat-Michel G
    Arch Pediatr; 2011 Jan; 18(1):33-6. PubMed ID: 21055910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vogt-Koyanagi-Harada disease associated with brainstem encephalitis.
    Hashimoto T; Takizawa H; Yukimura K; Ohta K
    J Clin Neurosci; 2009 Apr; 16(4):593-5. PubMed ID: 19201191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease.
    Al Dousary S
    J Laryngol Otol; 2011 Feb; 125(2):138-41. PubMed ID: 20880417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The clinical aspects of Vogt-Koyanagi-Harada disease in Belgium].
    Leys A; Vrijghem JC; van Ruymbeke K
    Bull Soc Belge Ophtalmol; 1989; 230():95-103. PubMed ID: 2488439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.